首页|Fujian Medical University Reports Findings in Personalized Medicine (Development of a novel disulfidptosis-correlated m6A/m1A/m5C/m7G gene signature to predict prognosis and therapeutic response for lung adenocarcinoma patients by integrate d…)
Fujian Medical University Reports Findings in Personalized Medicine (Development of a novel disulfidptosis-correlated m6A/m1A/m5C/m7G gene signature to predict prognosis and therapeutic response for lung adenocarcinoma patients by integrate d…)
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NETL
NSTL
By a News Reporter-Staff News Editor at Robotics & Machine Learning DailyNews Daily News – New research on Drugs and Therapies - Personalized Medicine is the subject of areport. According to news reporting ou t of Fuzhou, People’s Republic of China, by NewsRx editors,research stated, “Lu ng adenocarcinoma (LUAD) represents a significant global health burden, necessitating advanced prognostic tools for improved patient management. RNA modificatio ns (m6A, m1A,m5C, m7G), and disulfidptosis, a novel cell death mechanism, have emerged as promising biomarkers andtherapeutic targets in cancer.”
FuzhouPeople’s Republic of ChinaAsiaAdenocarcinomaCancerCyborgsDrugs and TherapiesEmerging TechnologiesG eneticsHealth and MedicineLung CancerLung Diseases and ConditionsMachine LearningOncologyPersonalized MedicinePersonalized Therapy
NETL
NSTL
